Accessing investigational anticancer agents outside of clinical trials.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Volumn 55, Issue 7, 1998, Pages

  Montello, M J ^a   Greenblatt, J J ^a   Fallavollita, A ^a   Shoemaker, D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; NEW DRUG;

ARTICLE; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HUMAN; NEOPLASM; PHARMACY; SALVAGE THERAPY; UNITED STATES;

ANTINEOPLASTIC AGENTS; DRUGS, INVESTIGATIONAL; HEALTH SERVICES ACCESSIBILITY; HUMANS; NATIONAL INSTITUTES OF HEALTH (U.S.); NEOPLASMS; PHARMACEUTICAL SERVICES; SALVAGE THERAPY; UNITED STATES;

MLCS; MLOWN;

EID: 0032040337     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/55.7.651     Document Type: Article

References (0)